Minato A - Search Results

1

Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma Patients or Those With a Poor Performance Status.

Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y, Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Song Y, Harada K, Kuroiwa K, Seki N, Fujimoto N, Nakamura M; Uro-Oncology Group in Kyushu (UROKYU). Furubayashi N, et al. Among authors: minato a. Anticancer Res. 2024 Aug;44(8):3409-3417. doi: 10.21873/anticanres.17161. Anticancer Res. 2024. PMID: 39060060

2

Retroreflector with acute dihedral angles.

Sugimoto N, Minato A. Sugimoto N, et al. Among authors: minato a. Opt Lett. 1994 Oct 15;19(20):1660-2. doi: 10.1364/ol.19.001660. Opt Lett. 1994. PMID: 19855614

3

Optical design of cube-corner retroreflectors having curved mirror surfaces.

Minato A, Sugimoto N, Sasano Y. Minato A, et al. Appl Opt. 1992 Oct 1;31(28):6015-20. doi: 10.1364/AO.31.006015. Appl Opt. 1992. PMID: 20733803

4

Optical design of a hollow cube-corner retroreflector for a geosynchronous satellite.

Minato A, Ozawa S, Sugimoto N. Minato A, et al. Appl Opt. 2001 Mar 20;40(9):1459-63. doi: 10.1364/ao.40.001459. Appl Opt. 2001. PMID: 18357137

5

Long-path absorption measurement of CO(2) with a Raman-shifted tunable dye laser.

Sugimoto N, Minato A. Sugimoto N, et al. Among authors: minato a. Appl Opt. 1993 Nov 20;32(33):6827-33. doi: 10.1364/AO.32.006827. Appl Opt. 1993. PMID: 20856536

6

Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer.

Minato A, Fujimoto N, Kubo T, Harada S, Akasaka S, Matsumoto T. Minato A, et al. Med Oncol. 2012 Dec;29(4):2895-900. doi: 10.1007/s12032-012-0178-z. Epub 2012 Feb 10. Med Oncol. 2012. PMID: 22323054

7

Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer.

Fujimoto N, Shiota M, Tomisaki I, Minato A. Fujimoto N, et al. Among authors: minato a. Clin Genitourin Cancer. 2017 Jun;15(3):337-342. doi: 10.1016/j.clgc.2017.01.006. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28188049 Review.

8

Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.

Minato A, Fujimoto N, Kubo T. Minato A, et al. Clin Genitourin Cancer. 2017 Dec;15(6):e1063-e1067. doi: 10.1016/j.clgc.2017.07.008. Epub 2017 Jul 22. Clin Genitourin Cancer. 2017. PMID: 28803791

9

Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ.

Tomisaki I, Kubo T, Minato A, Fujimoto N. Tomisaki I, et al. Among authors: minato a. Cancer Invest. 2018 Feb 7;36(2):152-157. doi: 10.1080/07357907.2018.1430815. Epub 2018 Feb 2. Cancer Invest. 2018. PMID: 29393701

10

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.

Minato A, Noguchi H, Tomisaki I, Fukuda A, Kubo T, Nakayama T, Fujimoto N. Minato A, et al. Cancer Control. 2018 Jan-Dec;25(1):1073274818800269. doi: 10.1177/1073274818800269. Cancer Control. 2018. PMID: 30213195 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters